Skip to main content
BioInfra Life Science Inc. logo

BioInfra Life Science Inc. — Investor Relations & Filings

Ticker · 266470 ISIN · KR7266470004 KO Professional, scientific and technical activities
Open in API
Filings indexed 121 across all filing types
Latest filing 2021-05-11 Regulatory Filings
Country KR South Korea
Listing KO 266470

About BioInfra Life Science Inc.

http://bioinfra.co.kr/?lang=en

BioInfra Life Science Inc. is a biotechnology company focused on cancer prevention, early detection, and treatment. The company's core technology is a multi-biomarker blood test, an in-vitro diagnostic solution designed for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This test analyzes cancer risk from a small blood sample. In addition to its diagnostic platform, the company develops cancer gene treatments and technologies to monitor the potential for metastasis and recurrence, aiming to provide innovative solutions in the healthcare field.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Regulatory Filings Classification · 95% confidence The document is a formal notification of an Investor Relations (IR) event held by Bioinfra Life Science. It details the date, location, participants, and agenda of the meeting. Since it is a short regulatory filing announcing the results of an IR event rather than the presentation slides themselves, it falls under the category of general regulatory announcements.
2021-05-11 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 95% confidence The document is a short, structured announcement (under 1,000 characters) reporting the results of an Investor Relations (IR) event held on May 6, 2021. It provides details on the date, location, and participants of the event, and notes that the presentation materials are available on the Korea IR Council website. Since it is an announcement of an event and the availability of materials rather than the presentation deck itself, it falls under the category of a regulatory filing announcement.
2021-05-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document type is used when an individual or entity acquires a significant stake (typically 5% or more) in a company's shares. In the provided classification schema, this corresponds to a 'Major Shareholding Notification'.
2021-04-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and board remuneration. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2021-03-31 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Bioinfra Life Science announcing the submission of their audit report (감사보고서 제출). It provides a summary of the audit opinion (unqualified/appropriate) and key financial highlights (assets, liabilities, net income) for the current and previous fiscal years. According to the 'Menu vs Meal' rule, this is an announcement of the audit report submission rather than the full audit report itself, making it a Report Publication Announcement (RPA). FY 2020
2021-03-23 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a comprehensive financial report for the fiscal year 2020, including the independent auditor's report, balance sheet, income statement, statement of changes in equity, cash flow statement, and detailed notes. It is not an announcement or a summary, but the full financial report itself. In the context of Korean corporate filings, this type of document is classified as an Annual Report (10-K equivalent). FY 2020
2021-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.